REQUEST FOR INFORMATION (RFI) Non-Invasive Transient Elastography Device NOTICE OF ACTION: This is a Request for Information (RFI) Only.
FibroScan® utilizes Vibration-Controlled Transient Elastography (VCTE) technology that appears to be the approach of choice to determine the degree of fibrosis. This has been validated in over 1,200 publications on the various aspects of effectiveness, efficacy, and accuracy of VCTE to help aid Physicians in their treatment of Liver Disease.
Description: FibroScan® Family of Products The Department of Veteran Affairs (VA), Strategic Acquisition Center (SAC), is soliciting offers under solicitation number 36C10G22R0022. This FibroScan® Brand-Name acquisition is 100% set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB). The North American Industry Classification code (NAICS) is 334510 - Electromedical and Electrotherapeutic Apparatus Manufacturing, Small Business Size Standard is 1,250 Employees, and the Product Service Code is 6525 Imaging Equipment and Supplies: Medical, Dental, Veterinary. The Contractor shall provide all supervision, labor, equipment, tools, and supplies necessary for the delivery of the FibroScan Family of Products that include the FibroS...
The FibroScan will monitor and detect hepatic steatosis and by utilizing transient elastography to identify veterans with Nonalcoholic Fatty Liver Disease (NAFLD) and significant fibrosis. The system will also assist in guiding HCV anti-viral therapy based on the fibrosis status. Determine the need for HCC surveillance before and after SVR. Monitor fibrosis progression in treatment naà ̄ve or failure veterans who cannot undergo treatment.
The FibroScan will monitor and detect hepatic steatosis and by utilizing transient elastography to identify veterans with NAFLD and significant fibrosis. The system will also assist in guiding HCV anti-viral therapy based on the fibrosis status. Determine the need for HCC surveillance before and after SVR. Monitor fibrosis progression in treatment naà ̄ve or failure veterans who cannot undergo treatment. Monitor fibrosis regression after SVR.
The unit shall be capable of Vibration Controlled Transient Elastography (VCTE) for non-invasive measurement of liver fibrosis and cirrhosis. The unit shall be capable of diagnosis and surveillance of chronic liver diseases, such as Hepatitis B, Hepatitis C, Autoimmune Hepatitis and Fatty Liver Disease, by utilizing VCTE to measure shear wave velocity passing through liver tissue.
